AT

Frank Wiesbrock


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Frank Wiesbrock: Innovator in Hybrid Polyester Materials

Introduction

Frank Wiesbrock is a notable inventor recognized for his contributions to the field of polymeric materials, particularly in medical applications. His innovative work focuses on developing materials that enhance hydrophilicity, which is crucial for various medical uses.

Latest Patents

Wiesbrock's most significant patent is titled "Hybrid Polyester Material With Enhanced Hydrophilicity For Medical Applications And Preparation Thereof." This invention relates to a novel polymeric material that comprises a biocompatible polyester selected from a group of materials, including poly(hydroxyalkanoate)s, poly(lactic acid)s, poly(glycolic acid)s, and poly(caprolactone)s. The biocompatible polyester is crosslinked with a functionalized poly(alkylene oxide) that contains at least two functional groups, which are essential for its application in medical fields. This innovative material is particularly useful for medical implants, bioresorbable implants, tissue engineering, and controlled release applications.

Career Highlights

Throughout his career, Frank Wiesbrock has worked at prestigious institutions, including the Technische Universität Graz and the Medical University of Graz. His work at these institutions has allowed him to contribute significantly to research and development in the field of medical materials.

Collaborations

Wiesbrock has collaborated with notable colleagues, including Clemens Ebner and Franz Stelzer, who have contributed to his research endeavors and innovations in polymeric materials.

Conclusion

Frank Wiesbrock's work in developing hybrid polyester materials with enhanced hydrophilicity represents a significant advancement in medical applications. His contributions continue to influence the field of biomedical engineering and material science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…